State of Tennessee, Treasury Department - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Tennessee, Treasury Department ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,437,365
+18.1%
52,757
-3.6%
0.01%
+20.0%
Q2 2023$1,217,075
-19.0%
54,700
-21.1%
0.01%
-28.6%
Q1 2023$1,501,818
+101718.2%
69,336
-4.5%
0.01%0.0%
Q4 2022$1,475
-20.8%
72,6360.0%0.01%
-22.2%
Q3 2022$1,863
-99.9%
72,636
+12.5%
0.01%
+28.6%
Q2 2022$1,536,000
-11.3%
64,586
-16.0%
0.01%0.0%
Q1 2022$1,732,000
+14.8%
76,933
+1.0%
0.01%
+16.7%
Q4 2021$1,509,000
-0.7%
76,170
-1.2%
0.01%0.0%
Q3 2021$1,519,000
-2.4%
77,115
+9.0%
0.01%0.0%
Q2 2021$1,557,000
-2.9%
70,755
+4.9%
0.01%
-14.3%
Q1 2021$1,604,000
-8.9%
67,419
+0.2%
0.01%0.0%
Q4 2020$1,760,000
+66.0%
67,288
+10.5%
0.01%
+40.0%
Q3 2020$1,060,000
-1.0%
60,870
-4.4%
0.01%0.0%
Q2 2020$1,071,000
+36.1%
63,643
-3.8%
0.01%
+25.0%
Q1 2020$787,000
-19.6%
66,160
-18.2%
0.00%0.0%
Q4 2019$979,000
-18.6%
80,877
-4.9%
0.00%
-33.3%
Q3 2019$1,202,000
+47.1%
85,087
+16.1%
0.01%
+50.0%
Q2 2019$817,000
-17.5%
73,278
-13.1%
0.00%
-20.0%
Q1 2019$990,000
+1.9%
84,365
+16.0%
0.01%0.0%
Q4 2018$972,000
+7.8%
72,739
+13.1%
0.01%
+25.0%
Q3 2018$902,000
-12.3%
64,327
-1.6%
0.00%
-20.0%
Q2 2018$1,028,000
-7.6%
65,393
-3.4%
0.01%
-16.7%
Q1 2018$1,113,00067,6790.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders